Moreover, PARP7 is indispensable for the anti-tumor properties of thioparib, as PARP7 KO MC38 cells treated with thioparib exhibit no tumor growth suppression, whereas PARP1 KO tumors remain sensitive. Here, PARP1 is linked to neoplasm.